Skip to main content
Molecular Therapy. Nucleic Acids logoLink to Molecular Therapy. Nucleic Acids
. 2022 Feb 3;27:969. doi: 10.1016/j.omtn.2022.01.023

Retraction Notice to: Upregulation of OIP5-AS1 Predicts Poor Prognosis and Contributes to Thyroid Cancer Cell Proliferation and Migration

Qiuli Li, Weichao Chen, Rongzhen Luo, Zhiyi Zhang, Ming Song, Wenkuan Chen, Zhongyuan Yang, Yuanzhong Yang, Zhuming Guo, Ankui Yang
PMCID: PMC8829494  PMID: 35211357

Main text

(Molecular Therapy: Nucleic Acids 20, 279–291; June 2020)

The corresponding author requested extensive changes to the manuscript following its publication, including the removal of all patient data from the manuscript, encompassing the removal of Figures 1A, 1C, 4E, 5H, and S3F and Tables 1 and 2, as well as substitutions of Figures 7E and 8. After reviewing these requests, the Editors feel the findings of the manuscript can no longer be relied upon and have decided to retract the paper. The corresponding author has agreed to the retraction.


Articles from Molecular Therapy. Nucleic Acids are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES